This resolution calls on the attorney general to intensify investigations into anticompetitive practices within the healthcare industry, particularly focusing on issues such as price-fixing and market allocation. It highlights the Supreme Court's previous rulings that affirm the applicability of antitrust laws to healthcare entities, including pharmaceutical companies. The resolution points out the significant disparities in healthcare pricing, noting that some pharmaceutical prices in the state are considerably higher than in other regions, and that healthcare costs have escalated to represent a substantial portion of the economy.

Furthermore, the resolution emphasizes the importance of ensuring compliance with antitrust laws to protect consumers and maintain fair market practices in the healthcare sector. It urges the attorney general not only to take action against identified anticompetitive behaviors but also to publicly disclose the rationale behind any decisions not to pursue legal action in such cases. This approach aims to promote transparency and accountability in the enforcement of laws designed to regulate the healthcare market.